{"nctId":"NCT03304873","briefTitle":"Retapamulin as a Decolonizing Agent for MRSA","startDateStruct":{"date":"2017-12-01","type":"ACTUAL"},"conditions":["MRSA"],"count":47,"armGroups":[{"label":"Retapamulin","type":"EXPERIMENTAL","interventionNames":["Drug: Retapamulin"]},{"label":"Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo Ointment"]}],"interventions":[{"name":"Retapamulin","otherNames":[]},{"name":"Placebo Ointment","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n1. Admission to the general pediatric floor and pediatric intensive care units at NYU Langone Medical Center or visit to study team members at ODA clinic (Park Ave locations) in Williamsburg Brooklyn.\n2. Ages 9 months to 17 years\n3. Residing in the zip codes which reflect Orthodox Jewish neighborhoods where there is a current outbreak of this strain of MRSA.\n4. Nasal and/or rectal culture positive for mupirocin-resistant methicillin-resistant Staphylococcus aureus (MRSA)\n\nExclusion Criteria:\n\nAn individual who meets any of the following criteria will be excluded from participation in this study:\n\n1. Pregnant or lactating\n2. Unable to appropriately consent\n3. Open sores in either of the study sites (nares or rectum)\n4. Recent surgical procedure to either study site (nares or rectum)\n5. Concurrent use of Rifampin or Trimethoprim/Sulfamethoxazole\n6. Current active MRSA infection\n7. Immunocompromised\n8. Presence of endotracheal tube, tracheostomy tube or other foreign body in upper airway","healthyVolunteers":false,"sex":"ALL","minimumAge":"9 Months","maximumAge":"17 Years","stdAges":["CHILD"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Number of Participants With MRSA Carriage at 1 Week Post Decolonization With Retapamulin or Placebo","description":"Study visit for nasal/peri-rectal swabs","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2","spread":null},{"groupId":"OG001","value":"13","spread":null}]}]}]},{"type":"PRIMARY","title":"Number of Partcipants With MRSA Carriage at 4 Weeks Post Decolonization With Retapamulin or Placebo","description":"Study visit for nasal/peri-rectal swabs","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"12","spread":null},{"groupId":"OG001","value":"9","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":23},"commonTop":["Local application site irritation"]}}}